Clinical trial
Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In…
NCT00134485 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00134485 |
|---|---|
| Title | Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia |
| Official title | Phase 3, Multi-Center, Double-Blind, Randomized, Parallel Group, Study of the Efficacy, Safety, and Tolerability of Fixed Combination Torcetrapib (CP-529,414) / Atorvastatin Administered Orally, Once Daily (QD) for Six Months, Compared With Maximally Tolerated Atorvastatin Therapy Alone, in Subjects… |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Familial, Hyperlipidemia |
| Intervention type | Drug |
| Interventions | torcetrapib/atorvastatin, atorvastatin |
| Enrollment | 400 |
| Start date | Mar 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Aug 24, 2005 |
| Last update posted | Oct 30, 2007 |
| Countries | Australia, Canada, Denmark, France, Iceland, Norway, South Africa, Sweden, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: